Navigation Links
Survival Favors the Prepared
Date:1/27/2009

As economic desperation splits the competitive hair even thinner, Munro & Associates steps up for their customers

TROY, Mich., Jan. 27 /PRNewswire/ -- "This is good for us and great for our customers," says Sandy Munro, Founder and CEO of Munro & Associates. "We can now deliver 21 years worth of experience more efficiently and cost effectively than ever before."

One missed step in today's climate could spell disaster. No company can afford to head into product development without first planning for everything. Worrying about things later is not an option. Competition is fierce and money is tight, so Munro & Associates is stepping up and providing their predictive tools more affordably so their customers can prepare and plan to be competitive in the coming markets.

"We are providing things like blended rates, software leases, and optimized service plans to help our customers," said Joe Feord, VP Business Development at Munro. "Our move in this direction is timely, considering the economy. Hiring Munro may also offer tax benefits with current expense deductions and possibly the R & D tax credit. We are teaming with our customers to drive earlier predictive analysis, infuse new technology, and make sure they have a solid winner right from the start."

Munro has packaged their Design Profit(R) methods and software suite along with extensive libraries and new process sheets to speed the time to market with higher confidence. These tools are easily plugged into a company's existing product development process.

Munro & Associates, Inc. has been their customers' voice for Value, Quality and Profit. Their experience scans thousands of examples and accounts for billions of dollars saved through more efficient product designs, higher quality and smoother production. Munro has expanded and refined their methods to offer predictive tools, metrics and methods to expose drivers of potential downstream problems, provide direction for designing out high-cost drivers, generate standardized metrics for early trade-off analyses, and manage the details for producability through the development life-cycle. By refining and repackaging how Munro works with their customers, these tools, metrics and methods are deployable more affordably than ever before.

About Munro and Associates, Inc.

Munro and Associates, Inc., founded in 1988, is headquartered in Troy, Michigan and has offices in Europe, Canada and Japan. Munro is a world-class consulting engineering firm that specializes in upfront, predictive methods to increase profitability by improving quality, reliability and value while reducing total life-cycle costs. The Munro team delivers in-depth knowledge in product design, manufacturing, quality and technologies from a broad selection of industries around the world.

Munro's diverse customer list includes TACOM LCMC, Tata Motors, Chrysler, Bentley, Rolls Royce, Oldenburg Group, General Dynamics, Rubbermaid, Cardinal Health, Boeing, Raytheon, ATK, Nikon, Lockheed Martin, and Knolls Atomic Power Laboratory.

For more information, visit http://www.leandesign.com

    Contact:

    Joe Feord, 248-362-5110 ext 206
    jfeord@leandesign.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Munro & Associates Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Institute Targets Brain Tumor Survival
2. Study examines racial disparities in survival among patients diagnosed with lung cancer
3. Optimal Treatment Boosts Blacks Lung Cancer Survival
4. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
5. Sepsis Therapy in Preemies Fails to Boost Survival
6. Minimizing obesitys impact on ovarian cancer survival
7. Family Needs to Know When Patient Survival Is Uncertain
8. Low Levels of 2 Enzymes in Ovarian Cancer Cells Shortened Survival
9. Clot Dissolver Doesnt Boost Survival in Cardiac Arrest Patients
10. An ESC statement on gender differences in medical care and survival after myocardial infarction
11. Tau protein expression predicts breast cancer survival -- though not as expected
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... Valentine’s Day is nearly upon us, and most singles ... great outfit, flawless hair, and a sparkling personality are all well and good, but ... night at home with Rover. (Actually, man’s best friend might not even want to ...
(Date:2/13/2016)... ... February 13, 2016 , ... Many individuals looking to lead a healthy lifestyle ... reasons. IsoPasta by Isolator Fitness has delved into this niche allowing those giving ... high-carb repercussions. IsoPasta has 30 grams of protein and only 7 grams of ...
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV are ... The increasingly modern world of instantaneous consumption proves very convenient for businesses. With new ... oil and coal, which pollutes our air, water, and soil. It can also threaten ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical Holdings, Inc. presented ... a VeinViewer® Vision vein finder for the nursing school simulation lab. ... and draw blood, combining technology with traditional technique. , “VeinViewer is a wonderful ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... In the ... forward. They’ll groom themselves to perfection, go out of their way to be romantic, ... – just take a look at any online dating profile. , A recent ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
Breaking Medicine Technology: